WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aprea Therapeutics earnings were -$13.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest APRE earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.9M, down 23.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, APRE reported annual earnings of -$13.0M, with -9.3% growth.

APRE earnings history

Current Revenue
$1.5M
Current Earnings
-$13.0M
Current Profit Margin
-862.4%

APRE Return on Equity

Current Company
-54.1%
Current Industry
-2%
Current Market
34.1%
APRE's Return on Equity (-54.1%)... subscribe to Premium to read more.
High Return on Equity Performance

APRE undefined

Current Company
-45.5%
Current Industry
-0.4%
APRE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when APRE announces earnings.

APRE undefined

Current Company
-69.1%
Current Industry
5.9%
APRE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APRE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
APRE-$14.23M-$12.96MN/A-$2.35
SLXN-$12.55M-$16.52MN/A-$26.36
RNAZ-$16.19M-$16.79MN/A-$16,785,572.00
EVGN-$10.63M-$16.49MN/A-$2.89
BCLI-$11.31M-$11.62MN/A-$2.31
View Top Biotech Stocks

Aprea Therapeutics Earnings Reports & History FAQ

What were Aprea Therapeutics's earnings last quarter?

On APRE's earnings call on Invalid Date, Aprea Therapeutics (NASDAQ: APRE) reported Q4 2024 earnings per share (EPS) of -$0.47, up 48.91% year over year. Total APRE earnings for the quarter were -$2.89 million. In the same quarter last year, Aprea Therapeutics's earnings per share (EPS) was -$0.92.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.

Is Aprea Therapeutics profitable or losing money?

As of the last Aprea Therapeutics earnings report, Aprea Therapeutics is currently losing money. Aprea Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$12.96 million, a 9.3% decrease year over year.

What was APRE's earnings growth in the past year?

As of Aprea Therapeutics's earnings date in Invalid Date, Aprea Therapeutics's earnings has grown year over year. APRE earnings in the past year totalled -$12.96 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.